Stein Jerry, Garty Ben Zion, Dror Yael, Fenig Eyal, Zeigler Marsha, Yaniv Isaac
Bone Marrow Transplantation Unit, Department of Pediatric Hematology/Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Eur J Pediatr. 2007 Jul;166(7):663-6. doi: 10.1007/s00431-006-0298-6. Epub 2006 Oct 11.
Wolman disease is a rapidly fatal lysosomal storage disease caused by the complete absence of lysosomal acid lipase activity. We report the cure of an infant with Wolman disease following transplantation of unrelated HLA-mismatched umbilical cord blood-derived stem cells. Umbilical cord blood was chosen as the stem-cell source because of its immediate availability and reduced tendency to cause graft-versus-host disease. The transplantation resulted in restoration of normal acid lipase levels before the onset of permanent end-organ damage. Four years after transplantation, the patient is thriving and has normal levels of acid lipase in peripheral blood cells. To our knowledge, this is the first report of a successful unrelated cord blood transplant in a patient with Wolman disease. Umbilical cord stem cells transplantation can restore acid lipase levels in Wolman disease, and if performed early, can cure the disease.
沃尔曼病是一种由溶酶体酸性脂肪酶活性完全缺乏引起的快速致死性溶酶体贮积病。我们报告了一名患有沃尔曼病的婴儿在接受不相关的HLA配型不合的脐血来源干细胞移植后治愈的病例。选择脐血作为干细胞来源是因为其可立即获得且引发移植物抗宿主病的倾向较低。移植导致在永久性终末器官损伤发生之前恢复了正常的酸性脂肪酶水平。移植四年后,该患者茁壮成长,外周血细胞中的酸性脂肪酶水平正常。据我们所知,这是沃尔曼病患者成功接受不相关脐血移植的首例报告。脐血干细胞移植可恢复沃尔曼病患者的酸性脂肪酶水平,并且如果早期进行,可治愈该疾病。